Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
A two-state cell damage model under hyperthermic conditions: theory and in vitro experiments
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas
Oncolytic vaccinia virus: from bedside to benchtop and back
Virus combinations and chemotherapy for the treatment of human cancers
Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia
[Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide]
Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients
Inoperable Pancoast tumors treated with hyperthermia-inclusive multimodality therapies
TIMP-1-GPI in combination with hyperthermic treatment of melanoma increases sensitivity to FAS-mediated apoptosis
Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C)
Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2
Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor
IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma
Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma
Dendritic cell vaccination with xenogenic polypeptide hormone induces tumor rejection in neuroendocrine cancer
CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo
Fusions of dendritic cells with breast carcinoma stimulate the expansion of regulatory T cells while concomitant exposure to IL-12, CpG oligodeoxynucleotides, and anti-CD3/CD28 promotes the expansion of activated tumor reactive cells
Regional hyperthermia in high-risk soft tissue sarcomas
Maximizing dendritic cell migration in cancer immunotherapy
Strategies to overcome obstacles to successful immunotherapy of melanoma